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background:  The role of the routine use of vascular imaging including intravascular ultrasound (IVUS) and Optical Coherence Tomography (OCT) in 
guiding percutaneous coronary interventions (PCI) is still controversial.
Methods:  We conducted a meta-analysis of available trials that compared imaging-guided PCI and angiography-guided PCI. We aimed to study 
both drug-eluting stents (DES) as well as bare metal stents (BMS). We identified 7 randomized controlled trials on IVUS-guided bare metal stents, 
3 randomized controlled trials and 9 registries on IVUS-guided drug-eluting stents and one registry that compared OCT-guided PCI to angiography-
guided PCI using either a BMS or a DES.
results:  Imaging-guided stenting was associated with a significant decrease in the Major Adverse Cardiac Events (MACE) in the DES patients 
(Odds ratio: 0.810. 95% CI: 0.719-0.912. P< 0.01) and combined DES and BMS patients (Odds ratio: 0.782. 95% CI:0.686-0.890. P<0.01). 
Imaging guidance was associated with significantly lower events of death of all causes in DES patients (Odds ratio: 0.654. 95% CI: 0.468-0.916. 
P<0.01) and in the combined DES and BMS patients (Odds ratio: 0.727. 95% CI: 0.540-0.980. P<0.01). The risk of Myocardial infarction (MI) was 
significantly lower with Imaging guidance in both, DES patients (Odds ratio: 0.551. 95% CI: 0.363-0.837. P<0.01) and combined DES and BMS 
patients (Odds ratio: 0.589. 95% CI: 0.425-0.816. P<0.01). This may be explained by the significantly lower risk of in-stent thrombosis in Imaging-
guided DES patients (Odds ratio: 0.651. 95% CI: 0.499-0.850. P< 0.01) and combined DES and BMS patients (Odds ratio: 0.665. 95% CI: 0.513-
0.862. P<0.01). Patients who received a DES showed no difference between Imaging guidance and angiography guidance in repeated target lesion 
revascularization.
conclusion:  Imaging-guided PCI significantly lowered the risk of death, MI, in-stent thrombosis and the combined MACE in DES implanted 
patients and all stented patients (DES or BMS). However, imaging guidance had no significant effect on repeated target vessel or target lesion 
revascularization in patients who received a DES likely due to the effect of the drug in the stent.
